Retrotransposon transcript increases have been linked to important hallmarks of Alzheimer's disease, most notably pathogenic tau, and this could be another mechanism by which TE‐associated cognitive impairments develop (Guo et al., 2018; Ramirez et al., 2022; Sun et al., 2018). Here, MAPT is linked to Alzheimer disease.